Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/173294
Title: Effect of the micro-environment on alpha-synuclein conversion and implication in seeded conversion assays
Author: Candelise, Niccolo
Schmitz, Matthias
Thüne, Katrin
Cramm, Maria
Rabano, Alberto
Zafar, Saima
Stoops, Erik
Vanderstichele, Hugo
Villar Piqué, Anna
Llorens Torres, Franc
Zerr, Inga
Keywords: Alfa-sinucleïna
Demència amb cossos de Lewy
Malaltia de Parkinson
Alpha-synuclein
Lewy body dementia
Parkinson's disease
Issue Date: 17-Jan-2020
Publisher: BioMed Central
Abstract: Background: α-Synuclein is a small soluble protein, whose physiological function in the healthy brain is poorly understood. Intracellular inclusions of α-synuclein, referred to as Lewy bodies (LBs), are pathological hallmarks of α- synucleinopathies, such as Parkinson’s disease (PD) or dementia with Lewy bodies (DLB). Main body: Understanding of the molecular basis as well as the factors or conditions promoting α-synuclein misfolding and aggregation is an important step towards the comprehension of pathological mechanism of α- synucleinopathies and for the development of efficient therapeutic strategies. Based on the conversion and aggregation mechanism of α-synuclein, novel diagnostic tests, such as protein misfolding seeded conversion assays, e.g. the real-time quaking-induced conversion (RT-QuIC), had been developed. In diagnostics, α-synuclein RT-QuIC exhibits a specificity between 82 and 100% while the sensitivity varies between 70 and 100% among different laboratories. In addition, the α-synuclein RT-QuIC can be used to study the α-synuclein-seeding-characteristics of different α-synucleinopathies and to differentiate between DLB and PD. Conclusion: The variable diagnostic accuracy of current α-synuclein RT-QuIC occurs due to different protocols, cohorts and material etc.. An impact of micro-environmental factors on the α-synuclein aggregation and conversion process and the occurrence and detection of differential misfolded α-synuclein types or strains might underpin the clinical heterogeneity of α-synucleinopathies.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s40035-019-0181-9
It is part of: Translational Neurodegeneration, 2020, vol. 9
URI: http://hdl.handle.net/2445/173294
Related resource: https://doi.org/10.1186/s40035-019-0181-9
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
CandeliseN.pdf2.12 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons